Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 20, 2026
W.R. Berkley (WRB) Q2 2026 Earnings Preview: Modest EPS Growth in Focus

W.R. Berkley (WRB) Q2 2026 Earnings Preview: Modest EPS Growth in Focus

Key Takeaways

  • Consensus EPS estimate for Q2 2026 stands at approximately $1.08 to $1.09.
  • Revenue consensus hovers near $3.20 billion, reflecting modest year-over-year growth.
  • Net investment income is projected around $395 million, up about 4% from the prior year.
  • Investors will focus on premium growth trends and underwriting margins in the property and casualty insurance sector.
  • Historical stock reactions to earnings have varied, with attention on any updates to full-year guidance.
  • Broader industry conditions, including interest rates and catastrophe losses, remain key themes.

Why This Report Matters for W.R. Berkley Corporation

W.R. Berkley Corporation operates as a property and casualty insurer with a diversified portfolio of specialty lines. Its quarterly results provide insight into premium pricing power, investment income, and loss trends that affect profitability. Following solid Q1 2026 performance with net income growth of 23.4%, the upcoming report offers a window into whether momentum continues amid evolving market conditions. For investors, these updates influence views on valuation and dividend sustainability in the insurance space. I also checked sector comparisons using Tickeron’s AI Screener to put the numbers in context.

What Analysts Are Projecting

Analysts project Q2 2026 earnings per share at a consensus of $1.08 to $1.09, marking a modest increase of roughly 3.8% year over year. Revenue expectations center on $3.20 billion. Net investment income is forecasted at about $395 million. These figures build on prior-quarter strength and reflect expectations for stable underwriting amid typical seasonal factors. Historical reactions to similar reports have often hinged on any deviations in loss ratios or updates to outlooks. From what I see in the data, the focus remains on whether results come in line with these measured forecasts.

Market Sentiment Ahead of the Release

Sentiment heading into the July 20 release appears measured, with focus on whether results align with or exceed modest consensus forecasts. Insurance sector peers have shown varied post-earnings moves depending on premium volume and investment yields. Key risk factors include potential surprises in catastrophe-related losses or shifts in interest rate expectations that could affect investment income. I’m watching this closely as any beat or miss could shape near-term trading.

Key Factors to Watch Going Forward

Following the Q2 report, investors will likely track any revisions to full-year guidance and comments on pricing trends across specialty lines. Demand signals in commercial insurance and the impact of recent rate environments on investment portfolios represent ongoing areas of interest. Cost management, including expense ratios, and potential impacts from weather-related events will also draw attention in upcoming quarters.

Broader industry dynamics, such as competition in underwriting and regulatory developments, could influence longer-term performance. Monitoring loss reserve adequacy and reinsurance costs provides additional context for assessing sustainability of recent profitability trends. These elements together shape expectations for how the company navigates the balance between growth and risk management in a competitive market.

How Tickeron Tools Fit Into My Research

In my analysis, I occasionally use Tickeron’s AI Screener to quickly scan for comparable names in the insurance space and spot

Related Ticker: WRB

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


WRB sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for WRB moved above the 200-day moving average on July 28, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WRB advanced for three days, in of 347 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 283 cases where WRB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for WRB moved out of overbought territory on July 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WRB as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for WRB turned negative on July 31, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

WRB moved below its 50-day moving average on August 11, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WRB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

WRB broke above its upper Bollinger Band on July 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 52, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. WRB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.660) is normal, around the industry mean (2.109). P/E Ratio (14.500) is within average values for comparable stocks, (15.548). Projected Growth (PEG Ratio) (4.761) is also within normal values, averaging (8.017). Dividend Yield (0.005) settles around the average of (0.023) among similar stocks. P/S Ratio (1.873) is also within normal values, averaging (1.569).

Industry description

Property and casualty companies insure against accidents of non-physical harm, such as lawsuits, damage to personal assets, car crashes and more. Progressive Corporation, Travelers Companies, Inc. and Allstate Corporation are some of the biggest providers of such products.

Market Cap

The average market capitalization across the Property/Casualty Insurance Industry is 13.75B. The market cap for tickers in the group ranges from 93.9K to 132.91B. CB holds the highest valuation in this group at 132.91B. The lowest valued company is UNAM at 93.9K.

High and low price notable news

The average weekly price growth across all stocks in the Property/Casualty Insurance Industry was -1%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 16%. AII experienced the highest price growth at 13%, while SKWD experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the Property/Casualty Insurance Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was -34%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 66
Price Growth Rating: 48
SMR Rating: 60
Profit Risk Rating: 52
Seasonality Score: -16 (-100 ... +100)
View a ticker or compare two or three
WRB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of financial services on the property and casualty insurance business

Industry PropertyCasualtyInsurance

Profile
Details
Industry
Property Or Casualty Insurance
Address
475 Steamboat Road
Phone
+1 203 629-3000
Employees
8329
Web
https://www.wrberkley.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.